Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013LEARN MORE>
Actavis Completes Forest Laboratories Acquisition

Executive Officers and Directors

Executive Officers
Paul M. BisaroExecutive Chairman, Actavis plc
Brent L. SaundersCEO & President
Robert A. StewartChief Operating Officer
Maria Teresa HiladoChief Financial Officer
David A. BuchenEVP, Commercial, North American Generics and International
Bill MeuryEVP, Commercial, North American Brands
Karen LingChief Human Resources Officer
Charles M. MayrChief Communications Officer – Global
Bob BaileyChief Legal Officer and Corporate Secretary
Jonathon L. KellermanEVP, Global Chief Compliance Officer
Nesli Basgoz, M.D.Associate Chief for Clinical Affairs, Division of Infectious Diseases, Massachusetts General Hospital (MGH)
Paul M. BisaroExecutive Chairman, Actavis plc
James H. BloemSenior Vice President, Chief Financial Officer and Treasurer, Humana Inc.
Christopher W. BodineFormer President, Health Care Services for CVS Caremark Corporation
Christopher J. CoughlinFormer Executive Vice President and Chief Financial Officer, Tyco
Tamar D. HowsonFormer Member of JSB-Partners
John A. King, Ph.D.Former Executive Chairman, Galen Holdings Ltd
Catherine  M.  KlemaLead Independent Director – President, Nettleton Advisors LLC
Jiri MichalFormer Chairman and Chief Executive Officer, Zentiva
Patrick J. O’SullivanFormer Chief Executive Officer, LEO Pharma Ireland
Brent L. SaundersCEO & President, Actavis plc
Ronald R. TaylorPresident, Tamarack Bay LLC
Andrew L. TurnerEnduracare Therapy Management, Inc.
Fred G. WeissManaging Director, FGW Associates, Inc.